Life Science and Diagnostic Tools Analyst Massaro hold meetings with Co-Founder, Chairman & CEO Robins and VP Calzadilla in New York on December 11 and in Boston on December 12 hosted by BTIG.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADPT:
- Adaptive Biotechnologies announces 65 abstracts to be presented at ASH meeting
- Adaptive Biotechnologies price target raised to $7 from $6 at Piper Sandler
- Adaptive Biotechnologies’ Q3 2024 Financial Performance Overview
- Adaptive Biotechnologies reports Q3 EPS (22c), consensus (29c)
- Adaptive Biotechnologies sees FY MRD business revenue $143 M-$145M
